Answers are grounded in this paper and cite their sources.
Parkinsons disease management remains heavily reliant on symptomatic treatments, which often lead to debilitating complications over time, creating a pressing need for interventions that offer durable benefits and potentially modify disease progression.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: